![](/img/cover-not-exists.png)
A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy
T Betts, T Waegemans, P CrawfordVolume:
9
Year:
2000
Language:
english
DOI:
10.1053/seiz.2000.0380
File:
PDF, 105 KB
english, 2000